| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(99)00024-8 |
| P698 | PubMed publication ID | 10193740 |
| P2093 | author name string | J Meyer | |
| R Erbel | |||
| L I Kupferwasser | |||
| H Darius | |||
| S Mohr-Kahaly | |||
| G Hafner | |||
| P2860 | cites work | Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 |
| Activation of cultured vascular endothelial cells by antiphospholipid antibodies. | Q33488617 | ||
| The lupus anticoagulant/antiphospholipid syndrome | Q33496329 | ||
| Antiphospholipid antibodies: basic immunology and assays | Q33499228 | ||
| Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study | Q34175310 | ||
| New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service | Q34339285 | ||
| Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation | Q34535595 | ||
| The protein C anticoagulant pathway | Q35225768 | ||
| Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges | Q35901415 | ||
| Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach | Q36149130 | ||
| Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts). | Q39947474 | ||
| Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress | Q40662150 | ||
| Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients | Q40676074 | ||
| Platelets and antiphospholipid antibodies | Q41197429 | ||
| Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis | Q41197517 | ||
| Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review | Q41440843 | ||
| Immunohematologic characteristics of infection-associated cerebral infarction | Q41884068 | ||
| Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications | Q43693632 | ||
| Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies | Q43719415 | ||
| Emboli in infective endocarditis: the prognostic value of echocardiography | Q44001110 | ||
| Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies | Q44728484 | ||
| Impairments of the protein C system and fibrinolysis in infection-associated stroke | Q46066077 | ||
| Infective endocarditis, 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. | Q52865325 | ||
| Coexistence of Anti-Phospholipid Antibodies and Endothelial Perturbation in Systemic Lupus Erythematosus Patients With Ongoing Prothrombotic State | Q58421342 | ||
| Cardiac involvement in patients with primary antiphospholipid syndrome | Q67977013 | ||
| Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications | Q68011532 | ||
| Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
| Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s | Q68235180 | ||
| Stroke in infective endocarditis | Q68510213 | ||
| Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects | Q69191536 | ||
| Anticardiolipin response in acute infections | Q69588484 | ||
| [The thrombophilic status of patients with inflammatory diseases] | Q71192658 | ||
| Effects of changes in management of active infective endocarditis on outcome in a 25-year period | Q72630490 | ||
| Infective endocarditis in the transesophageal echocardiographic era | Q72708009 | ||
| Transesophageal echocardiography in diagnosis of infective endocarditis | Q72770074 | ||
| Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation | Q74191181 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infective endocarditis | Q2450598 |
| P304 | page(s) | 1365-1371 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events | |
| P478 | volume | 33 |
| Q28165216 | A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis |
| Q34027413 | Anticoagulant therapy in special circumstances |
| Q40337946 | Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis |
| Q33886654 | Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk |
| Q89685761 | Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai |
| Q73661228 | Echocardiography predicts embolic events in infective endocarditis |
| Q44359913 | Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events |
| Q81864365 | Embolic Risk in Subacute Bacterial Endocarditis: Determinants and Role of Transesophageal Echocardiography |
| Q35065256 | Embolic risk in subacute bacterial endocarditis: determinants and role of transesophageal echocardiography |
| Q37624468 | Impact of stroke on therapeutic decision making in infective endocarditis |
| Q47865562 | Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. |
| Q41899627 | Infective Endocarditis Complicated by Acute Ischemic Stroke from Septic Embolus: Successful Solitaire FR Thrombectomy |
| Q35778535 | Infective endocarditis 2006: indications for surgery. |
| Q36490174 | Infective endocarditis: diagnosis and management |
| Q51751452 | Mean platelet volume predicts embolic complications and prognosis in infective endocarditis |
| Q92226421 | Prediction of Acute-phase Complications in Patients with Infectious Endocarditis |
| Q41357906 | Prevalence and significance of two major inherited thrombophilias in infective endocarditis. |
| Q47723521 | Risk factors for "major" embolic events in hospitalized patients with infective endocarditis |
| Q34591931 | The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. |
| Q38250442 | The role of hemostasis in infective endocarditis |
| Q28165218 | Toward reducing embolic complications from endocarditis |
| Q73734732 | Vegetations in endocarditis: big is bad, but is there more to it? |
| Q34354700 | Which antiphospholipid antibody tests are most useful? |
| Q52946041 | [Neurological complications of infective endocarditis]. |
Search more.